Skip to Content

Loretta Nastoupil

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2007 University of Texas Southwestern Medical Center, Dallas, TX, MD, Medicine
2003 Texas Tech University Health Science Center, Lubbock, TX, BS, Clinical Laboratory Science

Board Certifications

2013 American Board of Internal Medicine


Administrative Appointments/Responsibilities

Chief Fellow, Emory University School of Medicine, Atlanta, GA, 7/2012-6/2013

Institutional Committee Activities

Fellowship member, Hematology/Medical Oncology Fellowship Committe, 7/2012-6/2013

Selected Publications

Peer-Reviewed Original Research Articles

1. Bulka C, Nastoupil LJ, McClellan W, Ambinder A, Phillips A, Ward K, Bayakly AR, Switchenko JM, Waller L, Flowers CR. Residence proximity to benzene release sites is associated with increased incidence of non-Hodgkin lymphoma. Cancer 119(18):3309-17, 9/2013. e-Pub 7/2013. PMID: 23896932.
2. Nastoupil LJ, Sinha R, Flowers CR. The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy. Expert Rev Anticancer Ther 13(9):1089-108, 9/2013. e-Pub 8/2013. PMID: 23919536.
3. Shi Z, Das S, Okwan-Duodu D, Esiashvili N, Flowers C, Chen Z, Wang X, Jiang K, Nastoupil LJ, Khan MK. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. Int J Radiat Oncol Biol Phys 86(3):569-77, 7/2013. e-Pub 3/2013. PMID: 23540349.
4. Ambinder AJ, Shenoy PJ, Nastoupil LJ, Flowers CR. Using primary site as a predictor of survival in mantle cell lymphoma. Cancer 119(8):1570-7, 4/2013. e-Pub 1/2013. PMID: 23341329.
5. Rose AC, Shenoy PJ, Garrett G, Seward M, Kucuk RA, Doksansky H, Nastoupil LJ, Flowers CR. A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma. Clin Lymphoma Myeloma Leuk 12(6):393-9, 12/2012. PMID: 23158095.
6. Nastoupil LJ, Flowers CR. Management of relapsed chronic lymphocytic leukemia: applying guidelines to practice. Community Oncol 9(12):S85-S92, 12/2012. PMCID: PMC3541037.
7. Nastoupil L, Sinha R, Hirschey A, Flowers CR. Considerations in the initial management of follicular lymphoma. Community Oncol 9(11):S53-S60, 11/2012. PMCID: PMC3610920.
8. Chen Q, Ayer T, Nastoupil LJ, Seward M, Zhang H, Sinha R, Flowers CR. Initial management strategies for follicular lymphoma. Int J Hematol Oncol 1(1):35-45, 10/2012. PMCID: PMC3587762.
9. Flowers CR, Fedewa SA, Chen AY, Nastoupil LJ, Lipscomb J, Brawley OW, Ward EM. Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev 21(9):1520-30, 9/2012. PMID: 22771484.
10. Nastoupil LJ, Rose AC, Flowers CR. Diffuse large B-cell lymphoma: current treatment approaches. Oncology (Williston Park) 26(5):488-95, 5/2012. PMID: 22730604.
11. Nastoupil LJ, Sinha R, Flowers CR. Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma. Eur Oncol Haematol 8(2):123-126, 5/2012. PMCID: PMC3690666.
12. Sinha R, Nastoupil L, Flowers CR. Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future. Blood Lymphat Cancer 2012(2):87-98, 4/2012. PMCID: PMC3606548.
13. Flowers CR, Nastoupil LJ, Bernal-Mizrachi L, Rose AC, Sinha R. New Challenges in the Management of Diffuse Large B-Cell Lymphoma. Treat Strategies Hematol 2(1):68-73, 1/2012. PMCID: PMC3690658.
14. Ambinder AJ, Shenoy PJ, Malik N, Maggioncalda A, Nastoupil LJ, Flowers CR. Exploring risk factors for follicular lymphoma. Adv Hematol 2012:626035, 2012. e-Pub 9/2012. PMCID: PMC3458409.
15. Shenoy PJ, Malik N, Sinha R, Nooka A, Nastoupil LJ, Smith M, Flowers CR. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk 11(6):498-506, 12/2011. PMID: 21889433.

Last updated: 7/21/2014